BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2511684)

  • 21. [Hemodynamic and anti-angina effects of transdermal nitroglycerin after acute and chronic administration. Additive effect of sublingual isosorbide dinitrate].
    Scardi S; Pandullo C; Pivotti F; Ceschia G; Pollavini G
    G Ital Cardiol; 1986 Nov; 16(11):895-903. PubMed ID: 3104123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous long-term dosing with oral slow-release isosorbide dinitrate does not reduce incidence of cardiac events in patients with healed myocardial infarction.
    Kanamasa K; Hayashi T; Takenaka T; Kimura A; Ikeda A; Ishikawa K;
    Clin Cardiol; 2001 Sep; 24(9):608-14. PubMed ID: 11558843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis.
    Zarembski DG; Nolan PE; Slack MK; Caruso AC
    Arch Intern Med; 1993 Dec; 153(23):2661-7. PubMed ID: 7504440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ischemia tolerance of the heart in percutaneous transluminal coronary angioplasty. Controlled study of the effect of isosorbide dinitrate and nifedipine].
    Erbel R; Hüttemann M; Schreiner G; Darius N; Pop T; Meyer J
    Herz; 1987 Aug; 12(4):302-11. PubMed ID: 2958398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of isosorbide dinitrate on enzymatically estimated infarction size and on clinical condition of the patients of acute myocardial infarction.
    Mukherjee D; Lodh SK; Sengupta M; Maity AK; Mondal AK; Ghose JC
    Indian J Pathol Microbiol; 1990 Apr; 33(2):144-50. PubMed ID: 2391145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
    Ishikawa K; Kanamasa K; Ogawa I; Takenaka T; Naito T; Kamata N; Yamamoto T; Nakai S; Hama J; Oyaizu M; Kimura A; Yamamoto K; Aso N; Arai M; Yabushita H; Katori Y
    Jpn Circ J; 1996 Oct; 60(10):779-88. PubMed ID: 8933241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physiological Impact of Afterload Reduction on Cardiac Mechanics and Coronary Hemodynamics Following Isosorbide Dinitrate Administration in Ischemic Heart Disease.
    Patterson T; Rivolo S; Burkhoff D; Schreuder J; Briceno N; Allen C; Williams R; Arri S; Asrress KN; Joseph J; McConkey HZR; Ellis H; Pavlidis A; Clapp B; Perera D; Lee J; Marber MS; Redwood SR
    J Cardiovasc Transl Res; 2021 Oct; 14(5):962-974. PubMed ID: 33721195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of long-acting nitrate therapy on the risk of reinfarction, sudden death, and total mortality in survivors of acute myocardial infarction.
    Rapaport E
    Am Heart J; 1985 Jul; 110(1 Pt 2):276-80. PubMed ID: 4014000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Does long term treatment with high dose nitrates affect prognosis in coronary heart disease?].
    Bussmann WD; Giebeler B
    Klin Wochenschr; 1983 Apr; 61(8):423-8. PubMed ID: 6865271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial infarction: is bepridil, a new calcium antagonist, able to improve the course of the acute phase?
    Flammang D; Waynberger M; Paillet R; Pruvot C; Cosson G; Chassing A
    Cardiovasc Drugs Ther; 1989 Jan; 2(6):771-81. PubMed ID: 2488091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Long-term therapy following myocardial infarct with isosorbide dinitrate in a low and high dose].
    Kober G; Bettinger R; Klepzig H; Burger W; Schräder R; Kadel C; Fuchs H; Morawe G; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 2():122-6; discussion 142-4. PubMed ID: 2511684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [8-hour hemodynamic study of 2 sustained-release nitrate derivatives. Comparative double-blind study against placebo].
    Dubourg O; Guéret P; Ferrier A; Léger P; Farcot JC; Rigaud M; Beaumont D; Bardet J; Bourdarias JP
    Arch Mal Coeur Vaiss; 1983 Feb; 76(2):211-9. PubMed ID: 6407429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.